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1. Introduction 
Lactoferrin, the iron-binding protein of breast 
milk, is considered to be of great importance for the 
breast-fed infant. It has been shown [ 1,2] that lacto- 
ferrin can bind iron in vitro and in vivo, thereby 
preventing the growth of iron-requiring microorganisms. 
In addition the iron of breast milk is much more 
readily absorbed by the infant than iron in commer- 
cial formulas, where it is present in the form of added 
iron-salts [3] . 
Lactoferrin was first isolated almost simultaneously 
by Johansson [4], Montreuil and Mullet [5] and 
Blanc and Isliker [6]. It has been called ‘red protein’ 
and ‘lactotransferrin’ [6,7] although the commonly 
accepted name is lactoferrin. It has a mol. wt 80 000 
and is capable of binding 2 atoms of iron molecule. 
The concentration of lactoferrin in human milk varies 
from 3-4 mg/ml in early colostrum to l-2 mg/ml in 
mature milk [8,9]. 
In order to further investigate the physiological 
role of lactoferrin, it is necessary to have a pure prepa- 
ration of this protein. The only commercially available 
source contains about 20% impurities and the puritica- 
tion procedures described earlier are laborious. We 
have recently developed a new isolation procedure, 
metal-chelate affinity chromatography [lo] which is 
based on the property of certain proteins to bind transi- 
tion metals. A chelate-forming ligand is covalently 
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bound to a gel-forming matrix. The chelate is then 
established by saturating the gel-bound ligand with the 
desired metal-ion. 
The present paper describes the first application of 
the method. Since lactoferrin is capable of binding 
copper [I 1 ] as well as iron and since the copper- 
chelate-gel complex is much more stable than the iron 
complex, the copper-chelate-gel complex was chosen 
for the isolation of lactoferrin. 
2. Materials and methods 
2.1. Human milk 
Mature human milk was obtained from healthy well- 
nourished Swedish mothers 2-3 months after parturi- 
tion. The fat was removed by centrifugation at 
5000 X g for 20 min. Casein was precipitated by 
adjusting the skim milk with acetic acid to pH 4.6 
allowing to stand 1 h and centrifuging for 30 min at 
15 000 X g. The resulting whey (100 ml) was then 
dialyzed against the starting buffer of the affinity 
chromatography. 
2.2. Commercial lactoferrh 
Lyophilized human lactoferrin was obtained from 
Wakodo Co. (Tokyo, Japan). The purity was designat- 
ed 81% electrophoretically. Ten mg of the prepara- 
tion was dissolved in 10 ml of the starting buffer. 
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2.3. Metal chelate affinity chromatography 2.7. Biological activity 
The gel, bis-carboxymethyl amino agarose (Sepharose 
4B) was prepared as described by Porath et al. [lo] . 
The gel was packed in a column (3.2 X 5.5 cm) with 
total vol. 44 ml. The upper two-thirds of the column 
were saturated with copper-ions by frontal development 
with CuS04 (1 mg/ml). The bed thus prepared was 
washed with 0.05 M Tris-acetic acid buffer, pH 8.2 
in 0.5 M NaCl. The copper-ion-free part of the column 
serves to prevent any copper-ion emerging in the 
effluent from the column. The sample was followed 
by one column vol. of starting buffer and then eluted 
with a linear-gradient consisting of 500 ml starting 
buffer and 500 ml Tris-acetate acid, pH 2.8 in 0.5 M 
NaCl or stepwise by Tris-acetic acid buffer, pH 4.0, 
in 0.5 M NaCl. An 18 ml/h flow-rate and 6 ml fraction 
vol. were used. 
The bacteriostatic effect of lactoferrin was assayed 
by the inhibition of the growth of Escherichia coli 
with the method described by Reiter et al. [ 161. 
3. Results and discussion 
The metal-chelate affinity chromatography of the 
commercial lactoferrin preparation is shown in fig. 1. 
The column was eluted stepwise with the pH 4.0 
buffer. Immunoelectrophoresis by the method of 
Scheidegger [151 revealed that the material which 
passed through the metal-chelate column contained 
several proteins but no detectable amounts of lacto- 
ferrin. The eluted material contained the same amount 
of lactoferrin applied to the column and no other 
proteins. 
2.4. Molecular sieve chromatography 
Separation of the material eluted from the Cu-gel 
was carried out on Sephadex G-l 50 (Pharmacia Fine 
Chemicals, Uppsala, Sweden) (2.0 X 104.0 cm column) 
equilibrated with the starting buffer 14 ml/h flow-rate 
and 4 ml fraction vol. 
2.5. Immunoelectrophoresis 
Quantitat,ion of lactoferrin, secretory IgA and 
serum albumin was achieved by immunoelectrophoresis 
according to Laurel1 [ 121. The ‘fused rocket’ tech- 
nique described by Svendsen [ 131 was used to 
localize the specific proteins in the chromatograms. 
The agarose was alkali-treated to minimize electro- 
endosmosis [ 141. Immunoelectrophoresis as described 
by Scheidegger [151 was used for the analysis of the 
eluted materials. Anti-human whey proteins were 
obtained from Dakopatts (Copenhagen, Denmark) and 
Boehringerwerke (Mannheim, FRG). 
The elution profile was somewhat different when 
human whey proteins were separated on the column 
(fig.2a). The change in pH of the influent was linear 
but the pH of the effluent was higher at the beginning 
of the gradient due to the buffering capacity of the 
participating ions. All of the lactoferrin was adsorbed 
by the gel and all was desorbed by gradient-elution. 
However, secretory IgA and serum albumin also were 
adsorbed by the gel and desorbed by gradient-elution 
(tIg.2b). Serum albumin was separated from lactoferrin 
by adjusting the gradient of the eluting buffer but 
secretory IgA was not completely separated from lacto- 
ferrin. The separation of secretory IgA (mol. wt 
370 000) and lactoferrin (mol. wt 80 000) was how- 
ever easily achieved by gel-filtration on Sephadex 
Q 
2.6. Gel electrophoresis 
Polyacrylamide gel electrophoresis was performed 
by using a gel containing 8% acrylamide which in 
turn contained 2% bis-acrylamide (T&a). The gels 
were run in 0.9 M acetic acid for 3 h with current 
2 mA/gel. The staining solution was 0.1% Amido 
Black B in ethanol (20%) and acetic acid (7%). Excess 
stain was removed by washing with 7% acetic acid. 
Fig.1. Metal-chelate affinity chromatography of a commercial 
lactoferrin preparation. The column (3.2 X 5.5 cm) was 
equilibrated in 0.05 M Tris-acetic acid buffer, pH 8.2, in 
0.5 M NaCl. Elution: same buffer as above, at pH 4.0. 
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Fig.Z(a) Metal-chelate affinity chromatography of human milk proteins. The column (3.2 X 5.5 cm) was equilibrated in 0.05 M Tris 
Tris-acetic acid buffer, pH 8.2, in 0.5 M NaCl. Elution: 500 ml Tris-acetic acid buffer, pH 8.2 - 500 ml Tris-acetic acid buffer 
pH 2.8 (both in 0.5 M NaCI). (b) ‘Fused rocket’ immunoelectrophoresis of the fractions from Bg.2a against anti-IgA, anti-lactoferrin 
and anti-serum albumin. 
G-l 50 (fig.3). Only one component was detected by 
gel electrophoresis (fig.4) following the gel-filtration. 
Immunoelectrophoresis [151 also indicated that the 
purified lactoferrin did not contain detectable amounts 
of contaminating proteins. Atomic absorption spectro- 
scopy of the purified lactoferrin showed that no 
copper leaked from the column to the unsaturated 
lactoferrin and that no substitution of the lactoferrin- 
bound iron occurred. These findings coincide with the 
very strong binding of the copper to the gel and the 
weaker binding of iron. 
The recovery of lactoferrin was quantitative and the 
capacity of the column appeared to be very high. In 
fact, only a few millimeters of the column, as detected 
by the red colour of lactoferrin, was occupied by the 
lactoferrin (200 mg) in the chromatographic run of fig.2a, 
Fig.3 Gel-filtration of pooled material from fig.2a on Sephadex Fig.4. Polyacrylamide gel electrophoresis. Current 2 mA/gel, 
C-150 (2.0 X 104.0 cm) in 0.05 M Tris-acetic acid buffer, running time 3 h. Lf lactoferrin, HSA human serum albumin, 
pH 8.2, with 0.5 M NaCl. SIgA secretory IgA, a-La cu-lactalbumin. 
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suggesting that the binding capacity was about 70 mg 
lactoferrin/ml gel. The copper content of the gel was 
50 Eunollrnl gel. It should be pointed out that no 
protein adsorption occurred in a control experiment 
in which no copper had been complexed to the gel. 
As lactoferrin has been shown to be saturated to about 
lo-40% of its total iron-binding capacity [2] and all 
of the lactoferrin was adsorbed it is probable that 
surface-exposed histidine (and/or cysteine) residues 
of lactoferrin interact with Cu”-ions with excess 
binding capacity. The bacteriostatic activity of the 
lactoferrin as shown by the inhibition of growth of 
E. coli was intact after the purification procedure, 
indicating that the purification method does not 
cause any detectable damage to the protein. 
The present study indicates that metal-chelate 
affinity chromatography together with a gel-filtration 
provides a simple method for the isolation of human 
lactoferrin. 
In addition the method has the advantages of: 
(1) High capacity 
(2) Quantitative recovery 
(3) No detectable damage to the protein 
(4) Easy regeneration. 
Acknowledgements 
We are very grateful to Mrs Annika JBgare and 
Mr lngmar Olsson for skilful technical assistance. We 
are also grateful to Professor Leif Hambraeus for 
valuable support. For the atomic absorption analysis 
we wish to thank Dr Lennart Meurling and for the 
tests of bacteriostatic activity Drs Bruno Reiter and 
Lennart BjGrck. Financial support was obtained from 
the Medical Research Council (MFR) (project No. B76- 
19X-4722-02) and the Swedish Board for Technical 
Development (STU). 
References 
[ 11 Kirkpatrick, C. H., Green, I., Rich, R. R. and Schade, 
A. L. (1971) J. Infect. Dis. 124,539-544. 
[2] Bullen, J. J., Rogers, H. J. and Leigh, L. (1972) Brit. 
Med. J. 1,69-75. 
[ 31 Committee on Nutrition (1976) Pediatrics 58, 765-767. 
[4] Johansson, B. (1960) Acta Chem. Stand. 14,510-512. 
[5] Montreuil, J. and Mullet, S. (1960) C. R. Acad. Sci. 
250,1736-1737. 
[6] Blanc, B. and Isliker, H. (1961) Bull. Sot. Chim. Biol. 
43,929-943. 
[ 71 Montreuil, J., Biserte, G., Mullet, S., Spik, M. and Leroy, N. 
(1961) C. R. Acad. Sci. 252,4065-4067. 
[ 81 Nagasawa, T., Kiyosawa. I. and Kuwahara. K. (1972) 
191 
1101 
1111 
1121 
1131 
1141 
1151 
(161 
J. Dairy ici. 55, i651-i659. 
I .-- - 
LGnnerdal, B., Forsum, E. and Hambraeus, L. (1976) 
Am. J. Clin. Nutr. 29,1127-1133. 
Porath, J., Carlsson, J., Olsson, I. and Belfrage, G. 
(1975) Nature 258,598-599. 
Masson, P. L. and Heremans, J. F. (1968) Eur. J. Biochem. 
6,579-584. 
Laurell, C.-B. (1966) Anal. Biochem. 15,45-52. 
Svendsen, P. J. (1973) in: A Manual of Quantitative 
Immunoelectrophoresis (Axelsen, N. H., Kr@l, J. and 
Weeke, B. eds) pp. 69-70, Universitetsforlaget, Oslo. 
Lcnnerdal, B. and L%%s, T. (1976) Anal. Biochem. 72, 
527-532. 
Scheidegger, J. J. (1955) Int. Arch. Allergy 7, 103-110. 
Reiter, B., Brock, J. H. and Steel, E. D. (1975) Immuno- 
logy 28,83-95. 
92 
